Dr. Slovin on Approaches of Immunotherapy in Prostate Cancer – OncLive
OncLive |
Dr. Slovin on Approaches of Immunotherapy in Prostate Cancer
OncLive It’s important to recognize that immunotherapy encompasses more than checkpoint inhibitors, explains Slovin. There is a wide variety of other approaches that fall under the category of immunotherapy, such as antibodies, chimeric antigen receptor T … |
|
Favorable Safety Profile Seen in Immunotherapy Drug in Aggressive Form of Lung Cancer
Newswise (press release) Newswise — New Brunswick, N.J., August 16, 2017 – The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and “promising durable clinical activity” in pretreated patients who exhibit high levels of the PD-L1 protein in … |
|
Immunotherapy Company’s Q2 Revenue ‘Handily Beats’ HC Wainwright’s Projection
Streetwise Reports (registration) Selvaraju reminded investors of revenue expected from another corporate partnership, this one with ApolloBio, for development in China of Inovio’s DNA-based, nonsurgical immunotherapy, VGX-3100. This deal “involves an upfront payment of $15M and an … |
|
Batten Disease Clinical Trials Enrolling Patients to Evaluate Gene Therapies
Batten Disease News Gene therapies for children with Batten disease are being evaluated in two clinical trials — one in New York and the other in Ohio. The trials are testing ways to treat two types Batten disease by correcting the genetic defect that causes it. One … |
Devex |
A new mindset for the SDGs? Top takeaways from Singularity University’s Global Summit
Devex Singularity University faculty explain how exponentially growing technologies — such as artificial intelligence, digital manufacturing and synthetic biology — will enable us to make dramatic gains in the years ahead. Through online courses and the … |
|
Monsanto adds another CRISPR platform to genetic toolbox
Farm and Dairy ST. LOUIS — Monsanto Company has forged an agreement with ToolGen, Inc., a biotechnology company specializing in genome editing, to use ToolGen’s CRISPR technology platform to develop agricultural products. The companies announced Aug. 16 that … |
|
Monsanto adds another CRISPR platform to genetic toolbox
Farm and Dairy ST. LOUIS — Monsanto Company has forged an agreement with ToolGen, Inc., a biotechnology company specializing in genome editing, to use ToolGen’s CRISPR technology platform to develop agricultural products. The companies announced Aug. 16 that … |